STEMCELL Technologies plays crucial role in COVID-19 research and vaccine development
The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment
The company aims to provide solutions for the pandemic through close collaboration with scientists and providing cutting-edge laboratory equipment
Learn more about how BINDER is helping countless laboratories across the world conduct research into coronavirus.
Collaboration will enable global development, manufacturing and distribution of the vaccine
Pioneering new class of diagnostic product will transform fight against pandemic
The combination of the unique technologies aims to bring a novel angle to combat the global pandemic
Explore a compilation of some of the most innovative technology news relating to the novel coronavirus and the COVID-19 disease
With medical equipment in short supply, the 3D printing company steps up in coronavirus crisis
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines
The collaboration aims to develop novel, targeted treatments to address significant unmet needs
Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development
The test will be used on the m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.
The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA
The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes
IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19
Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020
New Gallant high-voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity
New platform could significantly reduce risks associated with counterfeit and falsified medications entering supply chains
New artifical intelligence algorithm could be the future of drug delivery
Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization
Incorporation of AI technologies highlights the most accurate compound predictions to enable effective project decision-making
Advanced analytical quality control and multi-sample visualization included in LIMS system upgrade